ESR1 and cancer: To evaluate the clinicopathological significance of EZH2 expression in metastatic lesions, we examined the correlations and changes in ER, PR, HER2, Ki-67 and EZH2 expression between primary cancer tissues and metastatic lesions, and DFS and OS outcomes after primary surgery and recurrence in patients with MBC.